Related Experiment Video
Updated: May 12, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Does early coronary artery bypass surgery improve survival in non-ST acute myocardial infarction?
Victor Dayan1, Gerardo Soca, Gabriel Parma
1Department of Cardiac Surgery and Cardiology, Cardiovascular Center, Hospital de Clinicas, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay. victor_dayan@hotmail.com
Insights
For non-ST myocardial infarction (NSTEMI) patients, coronary artery bypass graft (CABG) surgery after 6 hours is safe. Early CABG surgery in NSTEMI patients with high cardiac troponin I (cTnI) levels may increase risks; waiting for cTnI levels to decrease is advisable.
Area of Science:
- Cardiology
- Cardiac Surgery
- Evidence-Based Medicine
Background:
- Optimal timing for coronary artery bypass graft (CABG) surgery after non-ST myocardial infarction (NSTEMI) remains unclear.
- Current evidence is limited, with studies considering either surgical timing or myocardial damage extent.
Purpose of the Study:
- To determine if early or late CABG surgery improves outcomes in stable NSTEMI patients.
- To assess the impact of myocardial damage extent on CABG outcomes after NSTEMI.
Main Methods:
- A systematic review of 459 articles identified seven Level 3 retrospective cohort studies.
- Studies were categorized based on whether they assessed CABG outcomes using preoperative cardiac troponin I (cTnI) levels or solely timing after myocardial infarction.
Main Results:
- Operative mortality for CABG after NSTEMI is higher when performed within 6 hours; mortality is similar at any timepoint after 6 hours.
- Fewer postoperative complications are noted when CABG is performed after 48 hours, but no consensus exists on mortality differences between early (<48h) and late surgery.
- Higher preoperative cTnI levels (>0.15 ng/ml) are associated with increased major adverse cardiovascular events (MACEs) and hospital mortality. Specifically, cTnI >0.72 ng/ml within 24 hours of symptoms correlates with worse outcomes.
Conclusions:
- CABG surgery can be safely performed in NSTEMI patients after the initial 6 hours if cTnI levels are below 0.15 ng/ml.
- For NSTEMI patients with higher cTnI levels, delaying surgery until levels decrease may reduce MACEs and hospital mortality.
Abstract:
A best evidence topic was written according to a structured protocol. Lack of evidence exists regarding the optimal timing for coronary artery bypass graft (CABG) surgery after non-ST myocardial infarction (NSTEMI). While some authors address the importance of the timing of surgery alone, others take into account the extent of myocardial damage. The question addressed was whether early or late CABG surgery improves hospital mortality and cardiovascular events after NSTEMI in stable patients. Using a designated search strategy, 459 articles were found, of which seven represented the best available evidence. All of these studies were level 3 (retrospective cohort studies). Studies could be divided into those which assessed CABG outcome based on preoperative cardiac troponin I (cTnI) level as a measure of the extent of myocardial damage and those which considered only the timing after myocardial infarction. Outcome measures included short-term survival, hospital mortality, length of hospital stay and major adverse cardiovascular events (MACEs). The biggest retrospective study analysing postoperative outcomes based on the timing of surgery after NSTEMI concluded that operative mortality is higher when surgery is performed within 6 h of the event. After 6 h, mortality is similar at any timepoint after 6h of NSTEMI. While other smaller studies agree that there are fewer postoperative complications when surgery is performed after 48 h of the event, no consensus is found regarding mortality between early (less than 48 h) and late CABG surgery. Taking into account preoperative cTnI values, CABG has a higher incidence of MACEs and hospital mortality in patients with cTnI >0.15 ng/ml. When surgery is performed within 24 h of symptoms, preoperative cTnI >0.72 ng/ml is associated with worse outcomes. In view of the methodological limitations and level of evidence of the studies included, it appears that surgery may be safely performed in NSTEMI patients at any time after the first 6 h of the event in patients with cTnI <0.15 ng/ml, whereas in those patients with higher values of cTnI, waiting for cTnI to reduce before considering surgery seems to be a wise option in order to decrease the incidence of MACEs and hospital mortality.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management